Bluejay Diagnostics is a late-stage company focused on improving patient outcomes through a near patient product for triage, diagnosis and monitoring of disease progression. Co.'s diagnostic system, which Co. refers to as Symphony, which is an automated diagnostic system, consisting of a fluorescence immuno-analyzer which uses a single-use diagnostic test cartridge with reagents integrated into the cartridge. Symphony utilizes a sample-to-result format, which means that once a specimen is taken from the patient, it is placed in the cartridge and then the cartridge is placed inside the analyzer where the test is run without further technician intervention or additional reagent. We show 5 historical shares outstanding datapoints in our BJDX shares outstanding history coverage, used to compute BJDX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BJDX market cap history over the course of time is important for investors
interested in comparing BJDX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BJDX versus a peer is one thing; comparing
BJDX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BJDX can fluctuate over the course of history.
With this page we aim to empower investors researching BJDX by allowing them to research the BJDX market cap history. |
Free BJDX Email Alerts:
Video: The Importance of Market Cap
